Clinical Trial

Reducing Fluids Intakes in Neonatal Intensive Care

Study acronym: REFINI
Completed
View on ClinicalTrials.gov →
Summary
During stay in the neonatal intensive care unit, newborns requires various treatments administered intravenously. The hidden fluid intake associated with these infusion can lead to fluid overlad, increasing the risk of complications.This study aims to describe the variation of hidden fluid intake associated with treatment infusion, develop a new care protocol for the administration of intravenous medication in the neonatal intensive care unit, and finally standardize care practices related to the infusion of medication to improve the safety and quality of care for newborns.
Trial Details
NCT Number NCT07715513
Lead Sponsor University Hospital, Clermont-Ferrand
Conditions Neonatal Intensive Care Unit
Enrollment 9 participants
Start Date 2024-06-01
Primary Completion 2025-02-28 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-20